Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN50553029Phase 2Completed
Phase 2, randomised trial in Cardiovascular Malformation (CVM) comparing Fibrinogen concentrate with Placebo (2 arms). Primary endpoints: Fibrinogen concentration and Fibrin polymerization. Started Jun 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN50553029.